District Court: 340B Statute Isn’t Clear On Discounts Via Contract Pharmacies

The U.S. District Court for the District of Delaware on Wednesday (June 16) rejected the Biden administration’s request to dismiss AstraZeneca’s lawsuit challenging HHS’ effort to stop drug maker restrictions on 340B discounts on drugs dispensed via contract pharmacies, as the judge said the statue is vague on the issue. “Congress may very well want pharmaceutical manufacturers to deliver 340B drugs to an unlimited number of contract pharmacies as a condition for manufacturers’ participation in the Medicare Part B and...